Items where Author is "Du Pasquier, R."

Yes

Disanto, G. and Benkert, P. and Lorscheider, J. and Mueller, S. and Vehoff, J. and Zecca, C. and Ramseier, S. and Achtnichts, L. and Findling, O. and Nedeltchev, K. and Radue, E. W. and Sprenger, T. and Stippich, C. and Derfuss, T. and Louvion, J. F. and Kamm, C. P. and Mattle, H. P. and Lotter, C. and Du Pasquier, R. and Schluep, M. and Pot, C. and Lalive, P. H. and Yaldizli, O. and Gobbi, C. and Kappos, L. and Kuhle, J. and Smsc Scientific Board, . (2016) The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PLoS One, 11 (3). e0152347.

Derfuss, T. and Curtin, F. and Guebelin, C. and Bridel, C. and Rasenack, M. and Matthey, A. and Du Pasquier, R. and Schluep, M. and Desmeules, J. and Lang, A. B. and Perron, H. and Faucard, R. and Porchet, H. and Hartung, H. P. and Kappos, L. and Lalive, P. H.. (2015) A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. Multiple Sclerosis Journal, 21 (7). pp. 885-893.

Derfuss, T. and Curtin, F. and Guebelin, C. and Bridel, C. and Rasenack, M. and Matthey, A. and Du Pasquier, R. and Schluep, M. and Desmeules, J. and Lang, A. B. and Perron, H. and Faucard, R. and Porchet, H. and Hartung, H. P. and Kappos, L. and Lalive, P. H.. (2015) A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up. Journal of Neuroimmunology, 285. pp. 68-70.

Kurmann, R. and Weisstanner, C. and Kardas, P. and Hirsch, H. H. and Wiest, R. and Lammle, B. and Furrer, H. and Du Pasquier, R. and Bassetti, C. L. and Sturzenegger, M. and Krestel, H.. (2015) Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine. J Neurovirol, 21 (6). pp. 694-701.